Know Cancer

forgot password

Multicenter Trial of CPE for Maxillofacial Prosthetics

Phase 3
21 Years
Open (Enrolling)
Facial Neoplasms, Head and Neck Neoplasms, Head Injuries, Penetrating, Birth Injuries

Thank you

Trial Information

Multicenter Trial of CPE for Maxillofacial Prosthetics

Maxillofacial prosthetics is a subspecialty of prosthodontics, providing the clinical
rehabilitation treatment of patients who have lost parts of the face due to cancer, trauma,
or birth defects. It is an orphan field that:

- treats few patients, making the subspecialty unprofitable for manufacturers to develop
new materials;

- offers fundamental rehabilitation and improvement in the quality of life to patients
who may have exhausted personal or third party funding; and

- provides a dental solution to an essentially medical problem.

Silicone rubber materials have been used for facial rehabilitation for more than 4 decades
with few improvements. There is a clear need for new, alternative, and more economic
materials for extraoral maxillofacial prostheses. Research at Gulf South Research Institute
in New Orleans by the Principal Investigator and others in the 1970s and 1980s developed an
alternative low-cost thermoplastic industrial rubber material (chlorinated polyethylene,
CPE) that met all toxicological (safety) and physical (effectiveness) requirements. A Phase
2 clinical trial at the time yielded equivocal results when compared to conventional but
costly silicone rubber products.

This research is a controlled, randomized, single-crossover, double-blinded
investigator-initiated multicenter Phase 3 clinical trial treating 100 patients that

- experimental thermoplastic CPE; and

- control silicone (Silastic Adhesive A/MDX4-4210) materials for non-inferiority of CPE
based on functional and subjective characteristics, and on the quality of life.

The clinical centers of the trial are at M.D. Anderson Cancer Center in Houston, Texas, and
at the Toronto Sunnybrook Regional Cancer Centre in Toronto, Canada.

Inclusion Criteria:

- Requires treatment for developmental or acquired extraoral facial defect

- Fully healed wound (6 months after surgery and/or radiation)

- Defect no larger than 9 x 12 cm (3.5 x 4.5 inches, the diameter of a giant bronze

- Cognizant enough to answer questionnaires

- Agrees to wear the prosthesis at least 6 hours per day

- Agrees to use the prescribed adhesive (Epithane-3 - now called Daro Adhesive Extra
Strength) and clean and store as instructed

- Plans to be able to return to the research institution for a 10 month period

- Able to manage prosthesis him/herself or with caregiver for a 10 month period

- Karnofsky score greater than or equal to 60

- No framework or implant/magnet retention

- No multiple recurrences of tumor

- No hypersensitivity to adhesives or test materials

- No current systemic or topical facial steroid treatment

- Not legally blind

- Not expected to have further surgeries to defect, radiation therapy, or other
cytoreductive therapy over the next 10 months

- No evidence of active skin condition/disease

- Not an infectious risk patient

Type of Study:


Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

Non-inferiority of chlorinated polyethylene elastomer (CPE) material

Outcome Time Frame:

10 month

Safety Issue:


Principal Investigator

Sudarat Kiat-amnuay, DDS MS

Investigator Role:

Study Chair

Investigator Affiliation:

University of Texas Dental Branch


United States: Federal Government

Study ID:




Start Date:

February 2005

Completion Date:

August 2012

Related Keywords:

  • Facial Neoplasms
  • Head and Neck Neoplasms
  • Head Injuries, Penetrating
  • Birth Injuries
  • Facial Neoplasms
  • Head and Neck Neoplasms
  • Head Injuries, Penetrating
  • Birth Injuries
  • Birth Injuries
  • Neoplasms
  • Facial Neoplasms
  • Head and Neck Neoplasms
  • Craniocerebral Trauma
  • Head Injuries, Penetrating



University of Louisville Louisville, Kentucky  40202